Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 8.32 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 8 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 8.16 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 8.88 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 7.42 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 8.59 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 9.04 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 4.11 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 0.0 | BCD100322A01 | 10 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 0.5 | BCD100322A03 | 10.8 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 1.0 | BCD100322A07 | 9.25 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 2.0 | BCD100322A11 | 9.43 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 4.0 | BCD100322A15 | 9.51 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 8.0 | BCD100322A19 | 10.4 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 12.0 | BCD100322A23 | 11 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 24.0 | BCD100322A27 | 11.3 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 8.02 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 8.09 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 8.54 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 8.39 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 6.31 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 7.02 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 4.95 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 0.5 | BCD100322A04 | 10.2 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 1.0 | BCD100322A08 | 9.7 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 2.0 | BCD100322A12 | 9.48 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 4.0 | BCD100322A16 | 8.07 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 8.0 | BCD100322A20 | 8.84 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 12.0 | BCD100322A24 | 9.22 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 24.0 | BCD100322A28 | 4.77 | pmol/sample |